Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Fortis Healthcare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
IL & FS Trust Company Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Malvinder Mohan Singh, Executive Chairman, Fortis Healthcare bags the Entrepreneur of the Year' award
The award further recognised Singh as a dynamic, young business leader who has made a mark on the global landscape 13-year-old girl walks normally after deformity correction surgery at Fortis Hospitals
Gaganashree, a 13-year-old girl from Bengaluru, has undergone a six-hour surgery for Spondylo-epiphyseal dysplasia, a rare genetic disorder. With this corrective surgery in Fortis Hospitals, the g... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Fortis Healthcare Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Outcome of Board Meeting
Fortis Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 23, 2016 has accepted the resignation of Mr. Udai Dhawan, a Non-Executive Director of the Company with immediate effect. Disclosure of Voting results of Results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results at the Results of Postal Ballot of the Company held on March 21, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Updates
Fortis Healthcare Ltd has informed BSE that one of the Company's stepdown subsidiary Company viz Fortis Cancer Care Limited has informed the Company that it has increased its shareholding in Lalitha Healthcare Private Limited (Lalitha) by 98972 equity shares (i.e. 12.2% of total share capital of Lalitha) of Rs. 10 each. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Credit Suisse Finance (India) Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Fortis Healthcare Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE